EnhancerAtlas

EnhancerAtlas annotates and catalogs enhancers across nine species, including human, mouse, and Drosophila, to identify distal cis-regulatory elements and support study of their roles in activating gene transcription.


Key Features:

  • Species coverage: Covers nine species, explicitly including human, mouse, and Drosophila.
  • Dataset scale: Integrates 16,055 genome-wide profiling datasets.
  • Experimental methods: Incorporates data from twelve high-throughput methods, including H3K4me1/H3K27ac, DNase-seq/ATAC-seq, P300, POLR2A, CAGE, ChIA-PET, GRO-seq, STARR-seq, and MPRA.
  • Enhancer catalog: Identifies 13,494,603 enhancers.
  • Tissue and cell-type diversity: Profiles enhancers across 586 tissue/cell types, including normal tissues, cancer cell lines, and cells at various developmental stages.
  • Enhancer–target prediction: Predicts enhancer–target gene relationships in human, mouse, and Drosophila.

Scientific Applications:

  • Functional genomics: Enables analysis of enhancer activity and its impact on gene transcription.
  • Comparative genomics: Supports cross-species comparisons of enhancer repertoires.
  • Evolutionary biology: Facilitates studies of enhancer evolution and conservation across species.
  • Development and disease research: Supports investigation of enhancers in embryogenesis, development, homeostasis, and cancer cell lines.

Methodology:

Integrates 16,055 genome-wide profiling datasets from twelve high-throughput experimental methods (H3K4me1/H3K27ac, DNase-seq/ATAC-seq, P300, POLR2A, CAGE, ChIA-PET, GRO-seq, STARR-seq, MPRA, etc.) to identify enhancers and predict enhancer–target gene relationships for human, mouse, and Drosophila.

Topics

Details

Tool Type:
web application
Added:
1/14/2020
Last Updated:
11/24/2024

Operations

Publications

Gao T, Qian J. EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue/cell types across nine species. Nucleic Acids Research. 2019. doi:10.1093/nar/gkz980. PMID:31740966. PMCID:PMC7145677.

PMID: 31740966
PMCID: PMC7145677
Funding: - National Institutes of Health: EY001765, EY024580, EY029548, GM111514